Publication

Impressive results for treatment of PCa recurrent disease with NanoKnife Therapy

No incontinence and no negative change in erectile function in prostate cancer patients with recurrent disease Can patients with returning prostate cancer get treatment without fear of incontinence and erectile dysfunction? A novel study shows they can: The Vitus Prostate Center presented data on recurrent disease at the Annual Meeting of the Radiological Society of…

Read more

Treating advanced prostate cancer with focal therapy

The effective and gentle therapy of prostate cancer with infiltration of the urinary sphincter may soon become more than wishful thinking. In his newest scientific publication, Prof. Stehling and his medical and scientific team have demonstrated the effective treatment of locally advanced, high-risk prostate cancer with focal therapy. In this case report, which was published…

Read more

Participation in Multi-Center Register Study for IRE

Medical doctors and scientists at the Vitus Prostate Center in Frankfurt/Offenbach have been using Irreversible Electroporation (IRE; product name: NanoKnife®) for the treatment of prostate cancer in about 600 cases over the last 7 years. In close collaboration with the inventor of the IRE-technology, Prof. Boris Rubinsky from the University of California in Berkeley, the…

Read more

Irreversible electroporation: Where We Stand and Where We Go

Irreversible electroporation (IRE) is the latest in the series of image-guided locoregional tumor ablation therapies. IRE is performed in a nearly nonthermal fashion that circumvents the „heat sink effect“ and allows for IRE application in proximity to critical structures such as bile ducts or neurovascular bundles, where other techniques are unsuitable. Prof. Michael Stehling and…

Read more

Treatment of Prostate Cancer with Irreversible Electroporation (IRE)

Irreversible Electroporation (IRE), over the last few years, has established itself as a novel method in the field of focal cancer ablation in many medical institutions worldwide. Based on a non-thermal technology, IRE destroys cells whilst preserving non-cellular tissue elements within the treatment field. This property makes IRE a gentle alternative for focal treatments of…

Read more

Global Congress on Prostate Cancer 2016

The medical and scientific team of Prof. Stehling, the world’s leading expert in the irreversible electroporation of prostate carcinomas, presented the current data and facts in a poster at this year’s PROSCA (Global Congress on Prostate Cancer). We would be pleased to send you a summary of the current figures on request. Read more

Read more